Williamson Susan B

EVP Susan B Williamson bought 2,800 shares of FRST at $11.15 on 2025-02-06 ($31.2K); cluster pattern with 2 other insiders in past 14 days

Williamson, an EVP and Director of Regulatory Relations, purchased 2,800 shares at $11.15, increasing her holdings by 50.0% to 8.4K shares. Her prior trades at FRST were both well-timed: a May 2023 buy returned +23.1% over 90 days, and another May 2023 buy returned +32.6%. A second buy order for this insider occurs on 2025-02-05 (outcome not yet measurable), suggesting sustained conviction. Notably, 2 other insiders also purchased within the past 14 days, forming a cluster buy pattern. Against this, the company reported negative full-year net income despite a current market valuation of $275.4M and P/E of 11.60, flagging profitability concerns that warrant scrutiny of the buying rationale. The stock is currently -16.0% from its 52-week high, providing some valuation anchor for this transaction.

EVP Williamson buys 220 FRST shares at $11.05; cluster buy with 2 other insiders in 14 days, stock -15.9% from 52-week high.

Susan B Williamson, EVP and Director of Regulatory Relations, purchased 220 shares at $11.05 on 2025-02-05, adding 4.1% to her 5.6K-share position. The transaction occurs within a cluster pattern, with 2 other insiders also buying FRST within the past 14 days. Williamson's prior purchases at FRST on 2023-05-17 and 2023-05-08 both posted positive 90-day returns (+23.1% and +32.6% respectively), demonstrating a pattern of well-timed accumulation at this ticker. However, the company reported a negative full-year net income in its most recent fiscal year, and the current stock price is 15.9% below its 52-week high, creating a mixed backdrop: a pattern of insider buying acumen at this ticker versus deteriorating fundamentals that warrant deeper inspection.